IRIS
DANIELI, Maria Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.484
EU - Europa 2.572
AS - Asia 1.768
SA - Sud America 536
AF - Africa 107
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.476
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.322
SG - Singapore 733
IT - Italia 566
BR - Brasile 453
CN - Cina 377
UA - Ucraina 375
DE - Germania 276
RU - Federazione Russa 260
IE - Irlanda 236
SE - Svezia 225
HK - Hong Kong 184
VN - Vietnam 172
GB - Regno Unito 155
DK - Danimarca 137
CA - Canada 111
FI - Finlandia 101
TR - Turchia 94
FR - Francia 90
KR - Corea 72
NL - Olanda 46
IN - India 42
CI - Costa d'Avorio 41
MX - Messico 41
MA - Marocco 40
AR - Argentina 31
PL - Polonia 25
AT - Austria 18
ZA - Sudafrica 17
BD - Bangladesh 16
BE - Belgio 15
ID - Indonesia 15
EC - Ecuador 13
ES - Italia 13
JP - Giappone 13
VE - Venezuela 12
LT - Lituania 10
CL - Cile 8
IQ - Iraq 8
PY - Paraguay 8
PK - Pakistan 7
AU - Australia 6
CO - Colombia 6
IR - Iran 6
CH - Svizzera 5
IL - Israele 5
RS - Serbia 5
TW - Taiwan 4
UZ - Uzbekistan 4
EU - Europa 3
JO - Giordania 3
PE - Perù 3
RO - Romania 3
AL - Albania 2
BH - Bahrain 2
CR - Costa Rica 2
EG - Egitto 2
HN - Honduras 2
KW - Kuwait 2
MD - Moldavia 2
NG - Nigeria 2
SA - Arabia Saudita 2
UG - Uganda 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DZ - Algeria 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NI - Nicaragua 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TG - Togo 1
Totale 10.476
Salva come PNG Salva come JPEG
Città #
Dallas 1.024
Ashburn 591
Singapore 454
Jacksonville 389
Chandler 388
Fairfield 257
Dublin 230
Boardman 226
Hong Kong 182
New York 159
Wilmington 150
Woodbridge 144
Los Angeles 104
Seattle 102
Houston 101
Munich 101
Ann Arbor 97
Beijing 94
The Dalles 88
Lawrence 87
Princeton 87
Des Moines 82
San Mateo 82
Moscow 70
Cambridge 66
Ho Chi Minh City 64
Montréal 62
Centro 59
Hefei 53
Mcallen 49
Ancona 43
São Paulo 42
Abidjan 41
San Diego 41
Hanoi 39
Buffalo 33
Montreal 31
Chicago 30
Turin 28
Milan 27
Mexico City 26
Helsinki 23
Warsaw 23
Washington 23
Orem 18
Pune 17
Redmond 16
Shanghai 16
London 15
Amsterdam 14
Brussels 14
Guangzhou 14
Stockholm 14
Wuhan 14
Santa Clara 13
Tokyo 13
Boston 12
Nuremberg 12
Poplar 12
Rio de Janeiro 12
Saint Petersburg 12
Atlanta 11
Brasília 11
Castelfidardo 11
Chennai 11
Johannesburg 11
Brooklyn 10
Columbus 10
Denver 10
Florence 10
Norwalk 10
Rome 10
Turku 10
Ankara 9
Bologna 9
Chiaravalle 9
Haiphong 9
Manchester 9
Salvador 9
Kilburn 8
Phoenix 8
Belo Horizonte 7
Charlotte 7
Curitiba 7
Palermo 7
Bergamo 6
Buenos Aires 6
Joinville 6
Massafra 6
Porto Alegre 6
Salt Lake City 6
Secaucus 6
Vienna 6
Baghdad 5
Blumenau 5
Caracas 5
Dhaka 5
Frankfurt am Main 5
Guayaquil 5
Istanbul 5
Totale 6.636
Salva come PNG Salva come JPEG
Nome #
Prurigo nodularis as the first manifestation of a common variable immunodeficiency 317
Expanding the mosaic functions of intravenous immunoglobulin 227
Insights from comparison of serum IgG4 between T2-eosinophilic asthma and eosinophilic granulomatosis with polyangiitis/idiopathic hypereosinophilic syndrome 208
Use of nailfold capillaroscopy for the early diagnosis of systemic sclerosis in patients with primary biliary cholangitis 188
Colonna vertebrale. Midollo spinale. Imaging 187
Clinical features and follow-up in patients with 22q11.2 deletion syndrome. 155
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 147
La scelta della maternità. Una guida alla decisione per le donne con LES 145
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITHOUT OVERT NEUROPSYCHIATRIC MANIFESTATIONS 139
IMMUNOSUPPRESSIVE THERAPY IN LUPUS NEPHRITIS: A RANDOMISED TRIAL OF LOW DOSE VERSUS HIGH DOSE INTRAVENOUS CYCLOPHOSPHAMIDE. THE EUROLUPUS NEPHRITIS TRIAL. 138
Cardiac involvement in polymyositis and dermatomyositis 138
A Case of CVID-Associated Inflammatory Bowel Disease with CTLA-4 Mutation Treated with Abatacept 131
7th International Immunoglobulin Conference: Immunomodulation. 126
6th International Immunoglobulin Symposium: poster presentations. 125
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. 125
Overexpression of the cytokine BAFF and autoimmunity risk 123
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: Results from the MAINTAIN Nephritis Trial 120
Incidence of malignancy in patients with common variable immunodeficiency according to therapeutic delay: an Italian retrospective, monocentric cohort study 118
Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. 117
A proteinuria cut-off level of 0.7 g /day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: Data from the MAINTAIN Nephritis Trial 117
The EuroMyositis registry: An international collaborative tool to facilitate myositis research 115
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019) 115
The ten-year follow-up data of the Euro-lupus Nephritis Trial comparing low-dose versus high-dose intravenous cyclophosphamide. 113
Subcutaneous IgG in the Myositis Spectrum Disorders 113
Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein. 110
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 110
Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome. 109
Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. 108
Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vasculitis. 108
Association tests with systemic lupus erythematosus (SLE) of IL10 arkers indicate a direct involvement of a CA repeat in the 5' regulatory region 107
Autoimmune thyroid diseases in patients with undifferentiated connective tissue disease. 107
Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. 106
Bullous SLE: response to methotrexate and relationship with disease activity 106
Autoimmunità, Gravidanza, Contraccezione, Terapia ormonale 105
Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). 104
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 103
Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. 102
la terapia con immunoglobuline endovena nel trattamento delle malattie autoimmuni 102
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. 100
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 100
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. 99
Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis. 97
Autoimmunità Gravidanza Contraccezione Terapia Ormonale 97
Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency 97
ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics 96
Dr. Guerra, et al reply 96
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases 94
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies 94
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 93
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 91
Alarmins in autoimmune diseases 90
Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration 89
Potential Anti-Tumor Activity of Intravenous and Subcutaneous Immunoglobulin 88
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. 87
Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes 86
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases. 85
Intravenous Immunoglobulin and Mycophenolate Mofetil for Long-Standing Sensory Neuronopathy in Sjögren's Syndrome 85
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial 85
Risk factors for Sjögren's syndrome: a case-control study. 83
Subcutaneous immunoglobulins in ocular myositis. 83
Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis. 82
Sinchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis. 82
Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. 81
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 81
La terapia immunosoppressiva nelle miositi refratttarie 80
Subcutaneous IgG in immune-mediate diseases: proposed mechanisms of action and literature review. 79
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 78
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 78
Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination 76
Systemic lupus in Europe at the change of the millennium: lessons from the "Euro-lupus Project" 76
High-dose Facilitated subcutaneous Immunoglobulin in a Patient with refractory Polymyositis and severe Interstitial Lung disease 76
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 76
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations 75
Intravenous immunoglobulin as a therapy for autoimmune conditions 74
Ultrasonographic contrast-enhanced study of sicca syndrome 74
The European Society for Immunodeficiencies (ESID) registry 2014 73
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions 72
Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. 72
Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus. 72
[Therapy of refractory rheumatoid arthritis. Cyclosporin and methotrexate combination] 71
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease 71
Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study. 70
Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. 69
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies 68
Recurrent myelitis in common variable immunodeficiency successfully managed with high-dose subcutaneous immunoglobulin. 68
Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus 66
Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. 65
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis 64
Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagnaet al 64
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis 64
Subcutaneous immunoglobulin G in idiopathic inflammatory myopathies: therapeutic implications. 63
Preliminary report on the use of subcutaneous immunoglobulin in severe inflammatory myopathies 63
Splenic microcalcifications in systemic lupus erythematosus 62
Valutazione obbiettiva strutturata della competenza clinica (osce) 62
Lessons from the "Euro-Lupus Cohort". 62
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project 59
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 57
Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies 56
Immunoglobulin Treatment inPolymyositis and Dermatomyositis 55
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies. 54
Totale 9.839
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.469
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021657 0 0 0 0 0 58 131 60 120 87 134 67
2021/2022674 29 176 15 34 3 35 45 58 46 44 74 115
2022/20231.263 104 115 99 104 104 169 5 82 324 13 99 45
2023/2024915 158 40 56 123 143 188 18 34 10 32 19 94
2024/20251.759 134 170 75 31 66 94 178 91 326 158 180 256
2025/20263.490 306 878 629 654 695 328 0 0 0 0 0 0
Totale 10.707